Excited to share a major milestone for Biobeat!
Our latest research, published in JACC Journals: Advances, validates the accuracy and reliability of Biobeat’s noninvasive photoplethysmography (PPG) device for cardiac flow measurements, comparing it to the invasive pulmonary artery catheter.
This clinical study, conducted with heart failure patients, demonstrates the potential of our wearable technology to deliver seamless, real-time hemodynamic insights. With a correlation of 0.959 compared to invasive measurements, this breakthrough may revolutionize patient monitoring, reduce the need for invasive procedures, and improve personalized care.
We extend our gratitude to Dr. Rabea Asleh and Dr. Dean Nachman for their contribution to this important achievement.
👉 Read the full article- Biobeat_Cardiac_Flow_Assessment_2025.pdf
